Neurocrine Biosciences Inc. (0K6R)
LSE
Real-time Data
07:00 AM
Day's Range
153.0052 wk Range
118.72Overview - 0K6R - Neurocrine Biosciences Inc.
Key Statistics
Valuation
Enterprise Value
15.73B
P/E (Trailing)
‪2.11‬
Price / Book
‪4.23‬
EV / EBITDA
‪17.22‬
Profitability
Profit Margin
‪20.91%‬
Operating Margin
‪22.19%‬
Return on Assets
‪11.70%‬
Return on Equity
‪22.08%‬
Ownership
Shares Outstanding
90.68M
Float
100.38M
Held by Insiders
‪1.06%‬
Held by Institutions
‪102.80%‬
Price stats
Beta
‪0.39‬
50-Day Avg
‪135.58‬
200-Day Avg
‪114.15‬
Peers - 0K6R - Neurocrine Biosciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0K6RLSENeurocrine Biosciences Inc.13.97BMarket Cap+12.96%52-week change2.11P/E (Trailing)‪20.91%‬Profit Margin
- HLNLSEHaleon plc3.25TMarket Cap+3.25%52-week change20.17P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc340.01BMarket Cap+1.45%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB163.60BMarket Cap+35.36%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited154.69BMarket Cap-27.81%52-week change184.00P/E (Trailing)‪3.25%‬Profit Margin
- 0O14LSEMerck KGaA64.01BMarket Cap+20.52%52-week change19.49P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0K6R - Neurocrine Biosciences Inc.
About
Neurocrine Biosciences Inc. is a neuroscience-focused biopharmaceutical company specializing in the discovery, development, and commercialization of treatments for neurological, neuropsychiatric, endocrine, and metabolic disorders. Its flagship product, INGREZZA (valbenazine), a VMAT2 inhibitor, addresses tardive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
